Abstract
Background
lncRNAs are modulatory factors with critical function in the tumorigenesis pathways, introducing them as promising therapeutic and diagnostic biomarkers for different cancers. This study is thus aimed to evaluate the differences in PVT1 and ZFAS1 gene expression in tumorous tissues as compared with adjacent healthy non-tumorous biopsies of gastric cancer cases.
Methods
One hundred two pairs of tumorous and adjacent non-tumorous biopsies of GC cases were sampled. RNA isolation and cDNA production were carried out. The qRT-PCR was performed to evaluate the expression of PVT1 and ZFAS1 genes. Moreover, the associations between PVT1 or ZFAS1 and clinicopathological characteristics as well as the biomarker roles of the lncRNAs were assessed.
Results
The PVT1 and ZFAS1 expressions showed a significant increase and decrease in GC samples as compared with non-cancerous tissues, respectively. PVT1 expression was significantly associated with and lymph-node involvement (p = 0.0007). Moreover, ZFAS1 expression demonstrated a significant association with lymph-node involvement (p = 0.0005), and tumor size >5 cm (p = 0.003). The findings of the ROC curve revealed that PVT1 and ZFAS1 may act as a possible biomarker with AUC of 0.71 and 0.79, specificity of 78.43% and 79.41%, and sensitivity of 55.88% and 64.71%.
Conclusions
Regarding upregulation of PVT1 and downregulation of ZFAS1 in human GC samples, these genes may respectively act as oncogenic and tumor-suppressive factors in GC cases. Furthermore, PVT1 and ZFAS1 can be considered as possible biomarkers for the detection and treatment of GC cases.
Similar content being viewed by others
Data availability
The data are available if requested by the Editor or reviewers.
References
Rajabi A, Riahi A, Shirabadi-Arani H, Moaddab Y, Haghi M, Safaralizadeh R (2020) Overexpression of HOXA-AS2 LncRNA in patients with gastric cancer and its association with helicobacter pylori infection. J Gastrointest Cancer. https://doi.org/10.1007/s12029-020-00549-y(PMID: 33174119)
Kalan Farmanfarma K, Mahdavifar N, Hassanipour S, Salehiniya H. Epidemiologic study of gastric cancer in iran: a systematic review. Clin Expt Gastroenterol 2020;13:511–42 b (PMID: 33177859)
Dastmalchi N, Safaralizadeh R, Banan Khojasteh SM. The correlation between microRNAs and Helicobacter pylori in gastric cancer. Pathogens Dis 2019;77(4):ftz039 (PMID: 31351000)
Dastmalchi N, Khojasteh SMB, Nargesi MM, Safaralizadeh R. The correlation between lncRNAs and Helicobacter pylori in gastric cancer. Pathogens Dis 2019;77(9):ftaa004 (PMID: 31981356)
Zhang X, Wang W, Zhu W et al (2019) Mechanisms and functions of long non-coding rnas at multiple regulatory levels. Int J Mol Sci 20(22):5573 (PMID: 31717266)
Behzadi S, Baradaran B, Hosseinpourfeizi MA, et al. BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 2020 (PMID: 32914372)
Feng LL, Shen FR, Zhou JH, Chen YG (2019) Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity. Gene 696:105–112 (PMID: 30738960)
Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. BioMed Res Int 2015;2015:304208 (PMID: 25883951)
Onagoruwa OT, Pal G, Ochu C, Ogunwobi OO (2020) Oncogenic role of PVT1 and therapeutic implications. Front Oncol 10:17 (PMID: 32117705)
Yuan CL, Li H, Zhu L, Liu Z, Zhou J, Shu Y (2016) Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma 63:442–449 (PMID: 26925791)
Askarian-Amiri ME, Crawford J, French JD et al (2011) SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17(5):878–891 (PMID: 21460236)
Nie F, Yu X, Huang M et al (2017) Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget 8(24):38227–38238 (PMID: 27246976)
Herrero R, Heise K, Acevedo J, et al. Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: the ENIGMA study in Chile. PloS One 2020;15(9):e0237515 (PMID: 32898138)
Baj J, Korona-Glowniak I, Forma A et al (2020) Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in helicobacter pylori-induced gastric cancer. Cells 9(4):1055 (PMID: 32340207)
Riquelme I, Saavedra K, Espinoza JA et al (2015) Molecular classification of gastric cancer: towards a pathway-driven targeted therapy. Oncotarget 6(28):24750–24779 (PMID: 26267324)
Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE (2018) Epidemiology of helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins 10(4):163 (PMID: 29671784)
Tan H, Zhang S, Zhang J et al (2020) Long non-coding RNAs in gastric cancer: new emerging biological functions and therapeutic implications. Theranostics 10(19):8880–8902 (PMID: 32754285)
Gyvyte U, Kupcinskas J, Juzenas S, et al. Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs). PloS One 2018;13(12):e0209342 (PMID: 30557328)
Ahmad I, Valverde A, Ahmad F, Naqvi AR (2020) Long noncoding RNA in myeloid and lymphoid cell differentiation, polarization and function. Cells 9(2):269 (PMID: 31979061)
Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96–118 (PMID: 33353982)
Dastmalchi N, Safaralizadeh R, Nargesi MM (2020) LncRNAs: potential novel prognostic and diagnostic biomarkers in colorectal cancer. Curr Med Chem 27(30):5067–5077 (PMID: 30827228)
Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Ranaee M, Akhavan-Niaki H (2021) LINC02688 and PP7080 as novel biomarkers in early diagnosis of gastric cancer. Non-coding RNA research 6:86–91
Mohammadzadeh A, Baradaran B, Dastmalchi N, Hashemzadeh S, Safaralizadeh R (2021) The Correlation between helicobacter pylori infection and Lnc-OC1 expression in gastric cancer tissues in an Iranian population. J Gastrointest Cancer 52(2):600–605 (PMID: 32529394)
Behzadi S, Baradaran B, Hosseinpourfeizi MA, Dastmalchi N, Rajabi A, Asadi M, Safaralizadeh R (2021) BC032913 as a novel antisense non-coding RNA is downregulated in gastric cancer. J Gastrointest Cancer 52(3):928–931 (PMID: 32914372)
Kangarlouei R, Irani S, Noormohammadi Z, Memari F, Mirfakhraie R (2019) ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric cancer. J Cell Biochem 120(8):12544–12548 (PMID: 30834580)
Chaleshi V, Asadzadeh Aghdaei H, Nourian M, Iravani S, Jalaeikhoo H, Rajaeinejad M, Khoshdel AR, Naghoosi H. Association of MALAT1 expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient. Gastroenterol Hepatol Bed Bench 2021 Spring ;14(2):108–114 (PMID: 33968337)
Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z (2020) Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 11(10):871 (PMID: 33067424)
Qiu C, Li S, Sun D, Yang S (2020) lncRNA PVT1 accelerates progression of non-small cell lung cancer via targeting miRNA-526b/EZH2 regulatory loop. Oncol Lett 19(2):1267–1272 (PMID: 32002028)
Wang H, Huang Y, Yang Y (2020) LncRNA PVT1 regulates TRPS1 expression in breast cancer by sponging miR-543. Cancer Manag Res 12:7993–8004 (PMID: 32982402)
Yan M, Pan XF, Liu Y, Zhao S, Gong WQ, Liu W (2020) Long noncoding RNA PVT1 promotes metastasis via miR-484 sponging in osteosarcoma cells. Eur Rev Med Pharmacol Sci 24(5):2229–2238 (PMID: 32196583)
Tian Z, Cao S, Li C et al (2019) LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. J Cell Physiol 234(4):4799–4811 (PMID: 30317572)
Chen M, Zhang R, Lu L et al (2020) LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Aging 12(21):22291–22312 (PMID: 33188158)
Kong R, Zhang EB, Yin DD et al (2015) Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer 14:82 (PMID: 25890171)
Martinez-Barriocanal A, Arango D, Dopeso H (2020) PVT1 long non-coding RNA in gastrointestinal cancer. Front Oncol 10:38 (PMID: 32083000)
Fan S, Fan C, Liu N, Huang K, Fang X, Wang K (2018) Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer. Mol Med Rep 17(5):6405–6412 (PMID: 29532866)
Tian FM, Meng FQ, Wang XB (2016) Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients. Eur Rev Med Pharmacol Sci 20(24):5126–5131 (PMID: 28051258)
Sharma U, Barwal TS, Khandelwal A et al (2021) LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie 182:99–107 (PMID: 33429003)
Acknowledgements
This work was a part of the project entitled “The assessment of non-coding RNAs function in human malignancies” (Grant Number: 3522) performed at the University of Tabriz. The authors appreciate the participation of patients in this study.
Funding
This project has been financially supported by the University of Tabriz (Grant Code: 3522).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
The research was approved by the ethical committee of the Medical University of Tabriz with the code of IR.TABRIZU.REC.1398.015.
Consent to participate
All participants signed an informed consent form.
Consent to publication
All participants signed informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dastmalchi, N., Tayefeh-Gholami, S., Rajabi, A. et al. PVT1 and ZFAS1 lncRNAs expressions and their biomarker value in gastric cancer tissue sampling among Iranian population. Mol Biol Rep 48, 7171–7177 (2021). https://doi.org/10.1007/s11033-021-06709-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06709-y